Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenQuadfi Lot Consistency and Safety in Adolescents and Adults
NCT02842853Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2016
- Primary completion
- Feb 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal A conjugate vaccine in meningococcal meningitis, sponsored by Sanofi. Started Jul 2016; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT02842853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02842853.